(PEDIG), for the Pediatric Eye Disease Investigator Group

Short-term Outcomes After Very Low-Dose Intravitreous Bevacizumab for Retinopathy of Prematurity

JAMA Ophthalmology | April 23, 2020 | Volume: 138 | Issue: 6 | Pages: 698

10.1001/jamaophthalmol.2020.0334 | PMID 32324197